pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,943 catalysts · 5,063 phase readout · 2,312 8k filing · 316 pdufa · 273 earnings · 108 phase 2 completion · 50 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 16 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,063
  • 8k filing2,312
  • pdufa316
  • earnings273
  • phase 2 completion108
  • phase 1 completion50
  • phase 1 2 completion28
  • phase 1 initiation22
  • phase 0 trial completion21
  • phase 1 2 initiation9
  • therapy area
    • Oncology87
    • Cardiology23
    • Immunology15
    • Infectious Disease12
    • Dermatology12
    • Ophthalmology8
    • Women's Health8
    • Pulmonology8
    • Pain6

    Date TBD

    50
    ›RECRUITINGphase readoutNCT05592938: Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)

    Sponsor: University Health Network, Toronto. Phase: NA. Conditions: Breast Cancer, Breast Cancer Recurrent

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03352258: Effect of Low Dose Radiotherapy on Brain Amyloidosis in the Treatment of Alzheimer's Disease

    Sponsor: Valentina Garibotto. Phase: NA. Conditions: Alzheimer Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04481555: Eosinophil-guided Reduction of Inhaled Corticosteroids

    Sponsor: Chronic Obstructive Pulmonary Disease Trial Network, Denmark. Phase: PHASE4. Conditions: COPD, Inhaled Corticosteroid, Azithromycin, COPD Exacerbation, Pneumonia

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06643455: Mindfulness Intervention for Improving Nutrition in the Digital Kitchen Among Stage I-III Breast Cancer Survivors, MIND Trial

    Sponsor: Fred Hutchinson Cancer Center. Phase: NA. Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07318155: A Study of SRSD107 in Participants With Chronic Coronary and/or Peripheral Arterial Disease

    Sponsor: Sirius Therapeutics Co., Ltd.. Phase: PHASE2. Conditions: Coronary Artery Disease (CAD), Peripheral Arterial Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03939026: Safety and Efficacy of ALLO-501 Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell or Follicular Lymphoma

    Sponsor: Allogene Therapeutics. Phase: PHASE1. Conditions: Relapsed/Refractory Large B Cell Lymphoma, Relapsed/Refractory Follicular Lymphoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05814055: The Potential of Kava in Enabling Tobacco Cessation - Its Holistic Effects in Managing Stress and Insomnia Associated With Abstinence

    Sponsor: University of Florida. Phase: PHASE2. Conditions: Smoking

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07381426: Ferric Citrate in Iron Deficiency Anemia During Pregnancy

    Sponsor: Dhaka Medical College. Phase: PHASE3. Conditions: Anemia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03004326: Clinical Transcriptomics in Systemic Vasculitis (CUTIS)

    Sponsor: Peter Merkel. Phase: . Conditions: Cryoglobulinemic Vasculitis (CV), Drug-induced Vasculitis, Eosinophilic Granulomatosis With Polyangiitis (EGPA), IgA Vasculitis, Isolated Cutaneous Vasculitis, Granulomatosis With Polyangiitis (GPA), Microscopic Polyangiitis (MPA), Polyarteritis Nodosa (PAN), Urticarial Vasculitis, Vasculitis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07410026: Diagnostic and Therapeutic Efficacy and Safety of Enteroscopy in Pediatric Patients

    Sponsor: Shandong University. Phase: . Conditions: Small Bowel Diseases

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07519915: Improvement of Understanding of Pediatric Sacral Neuromodulation: Therapeutic Strategies and Outcome Variables

    Sponsor: Friedrich-Alexander-Universität Erlangen-Nürnberg. Phase: NA. Conditions: Gastrointestinal Motility Disorders in Children, Hirschsprung Disease, Constipation - Functional

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT00231400: Pompe Disease Registry Protocol

    Sponsor: Genzyme, a Sanofi Company. Phase: . Conditions: Glycogen Storage Disease Type II, Pompe Disease

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07521592: Effect of Video-Based Versus Verbal Preoperative Information on Anxiety and Cortisol Levels in Elective Cesarean Section

    Sponsor: Elazıg Fethi Sekin Sehir Hastanesi. Phase: NA. Conditions: Preoperative Anxiety, Cesarean Section, Surgical Stress Response, Cortisol

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03173092: A Study of Ixazomib (NINLARO®) in Combination With Lenalidomide and Dexamethasone (IRD) for the Treatment of Participants With Multiple Myeloma (MM)

    Sponsor: Takeda. Phase: PHASE4. Conditions: Multiple Myeloma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02106611: Tissue and Functional Assessment of Myocardial Injury in Hodgkin Lymphoma (HL) Survivors

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: . Conditions: Hodgkin Lymphoma Survivor

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05562271: Clinical Trial of Low-dose Radiation Therapy in Patients With Knee Osteoarthritis (LoRD-KNeA Trial)

    Sponsor: Seoul National University Hospital. Phase: NA. Conditions: Knee Osteoarthritis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07351864: Finerenone Plus SGLT2 Inhibitors in Heart Failure

    Sponsor: Mansoura University. Phase: PHASE4. Conditions: Heart Failure

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07316764: Eccentric Cycling in Multiple Sclerosis Rehabilitation

    Sponsor: University of Liege. Phase: NA. Conditions: Multiple Sclerosis, Rehabilitation, Neuro-Degenerative Disease, Neurorehabilitation

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07499609: Prevalence and Risk Factors for Hypertension and Recoarctation in Patients Operated for Aortic Coarctation

    Sponsor: Institut Saint Pierre. Phase: . Conditions: Aortic Coarctation, Retrospective Studies, Cohort Studies, Hypertension, Risk Factors, Infant, Newborn, Postoperative Complications, Reoperation, Mortality, Death, Cardiac Surgery

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04088409: A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old With Active JIA-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis

    Sponsor: Eli Lilly and Company. Phase: PHASE3. Conditions: Uveitis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05344599: Evaluating the Prevalence of Acute Hepatic Porphyria in Postural Tachycardia Syndrome

    Sponsor: Vanderbilt University Medical Center. Phase: . Conditions: Postural Orthostatic Tachycardia Syndrome, Acute Hepatic Porphyria

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07417332: Determination of the Degree of Dynamic Stability of the Foot in Single-leg Support in Relation to the Foot Posture Index in Judokas

    Sponsor: Fundación Universidad Católica de Valencia San Vicente Mártir. Phase: . Conditions: Postural Balance, Foot Posture, Sports Injuries, Athletic Performance

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07160621: Culturally Adapted Mobile Treatment of Chronic Pain in Adolescent Survivors of Pediatric Cancer: A Randomized Clinical Trial

    Sponsor: St. Jude Children's Research Hospital. Phase: NA. Conditions: Childhood Cancer Survivor, Chronic Pain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05890716: AI-powered ECG Analysis Using Willem™ Software in High-risk Cardiac Patients (WILLEM)

    Sponsor: Idoven 1903 S.L.. Phase: . Conditions: Cardiomyopathies, Cardiac Arrest, Cardiac Arrhythmias, Sudden Cardiac Death

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06767306: Stereotactic Ablative Radiotherapy (XRT) and Immunotherapy for Oligometastatic Extracranial Melanoma

    Sponsor: Melanoma Institute Australia. Phase: PHASE2. Conditions: Melanoma Metastatic

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06593106: Cryodevitalization for the Treatment of Early Stage Lung Cancer, CRYSTAL Trial

    Sponsor: Vanderbilt-Ingram Cancer Center. Phase: NA. Conditions: Stage I Lung Cancer, Stage II Lung Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07460206: Pembrolizumab Plus Lenvatinib in REcurrent ccRCC Patients Failing permbroLizUmab aDjuvant trEatment

    Sponsor: Gruppo Oncologico Italiano di Ricerca Clinica. Phase: PHASE2. Conditions: ccRCC

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07464704: Infrasensor for Early Detection of a High-grade Obstructive NSTE-ACS

    Sponsor: Remote Cardiac Enablement. Phase: . Conditions: High Grade Obstructive NSTE-ACS

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04222504: Community-based Venues for Delivery of Healthcare Services: Proof of Concept Pilot

    Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Pre-Exposure Prophylaxis, STI, Contraceptive Usage

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07089784: Multiple Dose Study of MK-2828 in Participants With Type 2 Diabetes (MK-2828-003)

    Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE1. Conditions: Diabetes Mellitus, Type 2

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03683433: Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Chronic Myelomonocytic Leukemia, IDH2 Gene Mutation, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07093333: A Study in Participants With Anti-NMDAR Encephalitis and Anti-NMDAR Autoantibody-Associated Psychiatric Disease

    Sponsor: Arialys Australia Pty Ltd. Phase: PHASE2. Conditions: Anti-N-methyl-D-aspartate Receptor (NMDAR) Encephalitis (ANRE), Anti-N-methyl-D-aspartate Receptor (NMDAR) Antibody-associated Psychiatric Disease, Autoimmune Encephalitis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07462052: Talk Parenting Education Program II

    Sponsor: Oregon Research Behavioral Intervention Strategies, Inc.. Phase: NA. Conditions: Parenting Practices, Self Efficacy, Stress, Child Behavior, Emotional Adjustment, Sleep Problem, Parent-Child Relations

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07290738: Transcranial Magnetic Stimulation (TMS) for Negative Symptoms in Schizophrenia Spectrum Disorders

    Sponsor: The University of Texas Health Science Center, Houston. Phase: NA. Conditions: Schizophrenia Spectrum Disorder

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05848258: An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis

    Sponsor: Eli Lilly and Company. Phase: PHASE2. Conditions: Rheumatoid Arthritis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07353658: Effect of Intermittent Enteral Feeding in Severe Stroke

    Sponsor: Xijing Hospital. Phase: NA. Conditions: Severe Stroke, Enteral Nutrition

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05473858: Oraverse Versus Laser

    Sponsor: sara nabil. Phase: PHASE3. Conditions: Reversal of Local Anesthesia in Children

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06862648: Evaluating SUI-100™, A Non-Invasive Device for the Treatment of Stress Urinary Incontinence

    Sponsor: Acoustic Wave Cell Therapy, Inc.. Phase: NA. Conditions: Stress Urinary Incontinence (SUI)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07316426: Preoptimisation in Ventral Hernia Surgery

    Sponsor: Umeå University. Phase: NA. Conditions: Hernia, Hernia, Ventral, Hernia Incisional, Hernia, Umbilical

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07091643: Neuroimaging Markers of Midlife Depression and Cognitive Behavioural Therapy (CBT)

    Sponsor: Baycrest. Phase: NA. Conditions: Major Depressive Disorder (MDD)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05419115: Use of a Novel SUBCUTaneous Preparation of Furosemide to Facilitate Early Supported Discharge of Patients With Heart Failure

    Sponsor: NHS Greater Glasgow and Clyde. Phase: PHASE2. Conditions: Heart Failure

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07552415: Does Joint Immobilization Following Revision Total Knee Arthroplasty Improve Range of Motion Following Surgery?

    Sponsor: Hospital for Special Surgery, New York. Phase: NA. Conditions: Aseptic Revision Knee Arthroplasty, Stiffness Following Revision Knee Arthroplasty

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06171035: Use of 3D Printing High-fidelity Craniofacial Manikin to Teach Noninvasive Positive Pressure Ventilation

    Sponsor: Fu Jen Catholic University. Phase: NA. Conditions: Satisfaction, Personal

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04749667: Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis

    Sponsor: Haukeland University Hospital. Phase: PHASE1. Conditions: Multiple Sclerosis, Progressive Multiple Sclerosis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07485465: Lymphoedema Diagnosis and Treatment

    Sponsor: Fatih Sultan Mehmet Training and Research Hospital. Phase: . Conditions: Lymphedema, Artificial Intelligence (AI)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06309992: A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight (SYNCHRONIZE-MASLD)

    Sponsor: Boehringer Ingelheim. Phase: PHASE3. Conditions: Obesity, Non-Alcoholic SteatoHepatitis (NASH)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07006792: A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden

    Sponsor: Eli Lilly and Company. Phase: PHASE4. Conditions: Atopic Dermatitis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07261436: Performance Comparison of Large Language Models in TAP Block Ultrasound Interpretation

    Sponsor: Kanuni Sultan Suleyman Training and Research Hospital. Phase: . Conditions: Artificial Intelegence

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03037411: A Real World Evaluation of the ELUVIA Stent in Subjects With Lesions Located in the Femoropopliteal Arteries

    Sponsor: Boston Scientific Corporation. Phase: . Conditions: Arterial Occlusive Diseases, Atherosclerosis, Vascular Diseases, Arteriosclerosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07507734: Occlusal Splint and Exercise Therapy for Temporomandibular Disorders

    Sponsor: Acibadem University. Phase: NA. Conditions: Temporomandibular Disorders (TMD)

    full page →ctgov ↗
    ← prev
    page 63 of 159
    next →